Lupin Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:	500257	NSE Symbol:	LUPIN	P/E :	29.87
ISIN Demat:	INE326A01037	Div & Yield %:	0.39	EPS :	68.52
Book Value:	481.38	Market Cap (Rs. Cr.):	93,454.30	Face Value :	2

Date	Headline
21-Mar-25	Lupin allots 24,101 equity shares under ESOP
17-Mar-25	Lupin receives USFDA tentative approval for Amifampridine Tablets
07-Mar-25	Lupin launches Rivaroxaban Tablets USP, 2.5 mg in the US
27-Feb-25	Lupin allots 59,940 equity shares under ESOP
21-Feb-25	Lupin receives EIR for its Somerset facility
19-Feb-25	Lupin receives 'A-' leadership rating from CDP
12-Feb-25	Board of Lupin approves transfer of OTC consumer healthcare biz to new subsidiary
10-Feb-25	Lupin and Natco receives USFDA approval for Bosentan Tablets for Oral Suspension
28-Jan-25	Lupin announces board meeting date
08-Jan-25	Lupin receives Establishment Inspection Report for its Pithampur Unit-1

Company Snapshot